VandenbergheN, ValletAE, PetitjeanT, Le CamP, PeyssonS, GuérinC, et al. Absence of airway secretion accumulation predicts tolerance of noninvasive ventilation in subjects with amyotrophic lateral sclerosis. Respir Care, 2013; 58(9):1424-1432.
2.
VitaccaM, VianelloA, on behalf of the Scientific Group on Respiratory Intensive Care of the Italian Association of Hospital Pulmonologists. Respiratory outcomes of patients with amyotrophic lateral sclerosis: an Italian nationwide survey. Respir Care, 2013; 58(9):1433-1441.
BourkeSC, TomlinsonM, WilliamsTL, BullockRE, ShawPJ, GibsonGJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol, 2006; 5(2):140-147.
5.
AboussouanLS, KhanSU, BanerjeeM, ArroligaAC, MitsumotoH. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve, 2001; 24(3):403-409.
6.
KleopaKA, ShermanM, NealB, RomanoGJ, Heiman-PattersonT. BiPAP improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci, 1999; 164(1):82-88.
7.
Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest, 1999; 116(2):521-534.
8.
MillerRG, JacksonCE, KasarskisEJ, EnglandJD, ForshewD, JohnstonW, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2009; 73(15):1218-1226.
9.
BourkeSC, BullockRE, WilliamsTL, ShawPJ, GibsonGJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology, 2003; 61(2):171-177.
10.
JacksonCE, LovittS, GowdaN, AndersonF, MillerRG. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler, 2006; 7(2):80-85.
11.
YuenEC, OlneyRK. Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis. Neurology, 1997; 49(2):573-578.
12.
SchmidtEP, DrachmanDB, WienerCM, ClawsonL, KimballR, LechtzinN. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve, 2006; 33(1):127-132.
13.
GruisKL, BrownDL, SchoennemannA, ZebarahVA, FeldmanEL. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve, 2005; 32(6):808-811.
14.
JacksonCE, RosenfeldJ, MooreDH, BryanWW, BarohnRJ, WrenchM, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci, 2001; 191(1-2):75-78.
15.
PintoA, de CarvalhoM, EvangelistaT, LopesA, Sales-LuisL. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord, 2003; 4(1):31-35.
16.
LechtzinN, ScottY, BusseAM, ClawsonLL, KimballR, WienerCM. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler, 2007; 8(3):185-188.
17.
AboussouanLS, KhanSU, MeekerDP, StelmachK, MitsumotoH. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med, 1997; 127(6):450-453.
18.
MillerRG, AndersonF, BrooksBR, MitsumotoH, BradleyWG, RingelSP. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol, 2009; 65(Suppl 1):S24-S28.
19.
OlneyRK, MurphyJ, ForshewD, GarwoodE, MillerBL, LangmoreS, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology, 2005; 65(11):1774-1777.
20.
CedarbaumJM, StamblerN, MaltaE, FullerC, HiltD, ThurmondB, NakanishiA. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci, 1999; 169(1-2):13-21.
21.
NorrisFHJr, CalanchiniPR, FallatRJ, PanchariS, JewettB. The administration of guanidine in amyotrophic lateral sclerosis. Neurology, 1974; 24(8):721-728.
22.
FattoriB, GrossoM, BongioanniP, NacciA, CristofaniR, AlSharifA, et al. Assessment of swallowing by oropharyngoesophageal scintigraphy in patients with amyotrophic lateral sclerosis. Dysphagia, 2006; 21(4):280-286.
23.
SuarezAA, PessolanoFA, MonteiroSG, FerreyraG, CapriaME, MesaL, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil, 2002; 81(7):506-511.
24.
KuhnleinP, GdyniaHJ, SperfeldAD, Lindner-PflegharB, LudolphAC, ProsiegelM, RieckerA. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol, 2008; 4(7):366-374.
SanchoJ, ServeraE, DiazJ, MarinJ. Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 2007; 175(12):1266-1271.
27.
RavitsJ, PaulP, JorgC. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology, 2007; 68(19):1571-1575.
28.
RavitsJ, LaurieP, FanY, MooreDH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology, 2007; 68(19):1576-1582.
29.
McCoolFD, TzelepisGE. Dysfunction of the diaphragm. N Engl J Med, 2012; 366(10):932-942.
30.
Gonzalez-BermejoJ, Morelot-PanziniC, SalachasF, RedolfiS, StrausC, BecqueminMH, et al. Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler, 2012; 13(1):44-54.
31.
OndersRP, ElmoM, KhansariniaS, BowmanB, YeeJ, RoadJ, et al. Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc, 2009; 23(7):1433-1440.
32.
NishinoT. Problems associated with diaphragm pacing. Respiration, 2002; 69(1):12-13.
33.
SenentC, GolmardJL, SalachasF, ChinerE, Morelot-PanziniC, MeningerV, et al. A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotroph Lateral Scler, 2011; 12(1):26-32.
34.
ChatwinM, SimondsAK. The addition of mechanical insufflation/exsufflation shortens airway-clearance sessions in neuromuscular patients with chest infection. Respir Care, 2009; 54(11):1473-1479.
35.
VitaccaM, PaneroniM, TraininiD, BianchiL, AssoniG, SaleriM, et al. At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil, 2010; 89(5):401-406.
36.
MoranFC, SpittleA, DelanyC, RobertsonCF, MassieJ. Effect of home mechanical in-exsufflation on hospitalisation and life-style in neuromuscular disease: a pilot study. J Paediatr Child Health, 2013; 49(3):233-237.
37.
MiskeLJ, HickeyEM, KolbSM, WeinerDJ, PanitchHB. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest, 2004; 125(4):1406-1412.
38.
SanchoJ, ServeraE, BanulsP, MarinJ. Prolonging survival in amyotrophic lateral sclerosis: efficacy of noninvasive ventilation and uncuffed tracheostomy tubes. Am J Phys Med Rehabil, 2010; 89(5):407-411.
39.
VianelloA, ArcaroG, PalmieriA, ErmaniM, BraccioniF, GallanF, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care, 2011; 26(3):329.e7-e14.
40.
BachJR, GoncalvesMR, HonA, IshikawaY, De VitoEL, PradoF, DominguezME. Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus. Am J Phys Med Rehabil, 2013; 92(3):267-277.
41.
QureshiM, SchoenfeldDA, PaliwalY, ShuiA, CudkowiczME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler, 2009; 10(5-6):324-331.
